posted on 2025-11-25, 04:11authored byBin Li, Chunni Lu, Sara Oveissi, Jing Song, Kun Xiao, Damien Zanker, Mubing DuanMubing Duan, Jianxin Chen, Huji Xu, Quanming Zou, Chao Wu, Jonathan W Yewdell, Weisan ChenWeisan Chen
<p dir="ltr">The participation of dendritic cells (DCs) in CD8<sup>+</sup> T-cell-mediated allograft rejection is a long-standing question of great clinical relevance for tissue transplantation. Here, we show that Batf3<sup>−/−</sup> mice demonstrate delayed allo-skin graft rejection and are deficient in priming allo-specific CD8<sup>+</sup> T cells. Batf3<sup>−/−</sup> mouse priming is restored by transferring either purified CD8α<sup>+</sup> or CD103<sup>+</sup> DCs, demonstrating the critical role of these cells in alloreactivity. Using D<sup>b</sup>-restricted antiviral F5 transgenic T-cell receptor T cells, which we demonstrate are alloreactive with H-2K<sup>d</sup>, we show that cross-dressing of CD8α<sup>+</sup> and CD103<sup>+</sup> primes CD8<sup>+</sup> T-cell or allo-specific responses <i>in vitro</i> and <i>in vivo</i>. These findings suggest novel strategies for moderating tissue rejection based on interfering with DC cross-dressing or subsequent interaction with T cells.</p>
Funding
This project was partly supported by the NHMRC program grant 567122.